Skip to main content

Femara News

Nearly Half With Early-Stage Breast Cancer Extend Endocrine Therapy Beyond Five Years

FRIDAY, June 20, 2025 – Nearly 40 percent of women with stage I breast cancer and two-thirds with stage II decide to extend endocrine therapy, according to a study published recently in JNCI:...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Breast Cancer - Adjuvant, Female Infertility, Breast Cancer, Metastatic, Breast Cancer

Femara patient information at Drugs.com